Navigation Links
Study Reveals Better Results in Patients Suffering From Depression.

Patients suffer from various psychiatric disease and they throng the hospitals for treatment. Statistics show that a third of these people // suffer from mental depressions of different levels.

Drugs that are used to treat them had a lot of controversial opinion about them and hence a study was conducted to analyze the effect of these drugs on the patients.

The initial results were that the drugs showed better results in case of well-qualified white women. The patients seem to undergo better recovery in their first trail of antidepressants. Dr. Madhukar Trivedi at the University of Texas Southwestern Medical Center carried out this study, which was funded by the National Institute of Mental Health ($35 million).

But in the earlier times treating patients with depression was a very challenging task. The first set of antidepressants will not usually work with the patients and the doctors would have to mix and match various drugs in order to find the exact cure for the particular patient.

The study (STAR-D) involved monitoring of the doctors especially in the initial months of the antidepressant’s usage.

The main idea to go about with this study is that there were evidences proving that antidepressants on certain periods led to increased suicidal tendencies in children/teenagers.

The Food and Drug Administration (FDA) has ordered that the pharmaceutical companies include the risks of children on the product labels. The study also said that in the future they would analyze the adult risk of usage of these antidepressants.

The results of the study were that it did not show any suicidal tendencies among the subjects (3000) included in the study.

The STAR-D study, which is a six-year study, was analyzed in two steps.

In step one the patients were given a newer class of antidepressants of selective serotonin reuptakes (Celexa). It showed that white women who were well qualified and patients who suffered from less number of diseases recovered quickly with initial treatment than who had severe depression and a number of co-existing diseases.

Patients who were not cured moved to the second step where they were administered with different therapies for difficult to treat depressions.
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider of ... other difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene ... System is a complete system for culturing and transfecting human pluripotent stem ...
(Date:6/24/2016)... City, FL (PRWEB) , ... June 24, 2016 , ... ... inflammation common after venous procedures, dermaka cream can be incorporated into the post-surgical treatment ... and minor surgical procedures. , dermaka cream is very effective for bruising and ...
(Date:6/24/2016)... Edwardsville, IL (PRWEB) , ... June 24, 2016 ... ... Darryll Beard, DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State ... dental clinic Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: